Form 4: Medpace CEO Sells $17M in Shares

Medpace Holdings CEO August J. Troendle reported selling over $17 million worth of company common stock in early December 2025.

Summary

• August J. Troendle, CEO, Director, and 10% Owner of Medpace Holdings, Inc. (MEDP), reported sales of common stock.
• On December 1, 2025, 23,178 shares of common stock were sold at a weighted average price of $593.25 per share, totaling approximately $13,750,000.
• On December 2, 2025, an additional 5,698 shares were sold at a weighted average price of $590.47 per share, totaling approximately $3,364,000.
• These transactions were executed pursuant to a limit order placed during an open window period.
• Following these sales, direct beneficial ownership stands at 646,852 shares of common stock.
• Indirect beneficial ownership includes 4,733,019 shares through Medpace Investors, LLC, where August J. Troendle is the sole manager and controlling unit holder.

Sentiment

Score: 3

Explanation: The sale of a significant amount of common stock by the CEO and a 10% owner is typically viewed as a negative signal by the market, suggesting potential concerns about future growth or valuation.

Negatives

• Significant insider selling by the CEO and a 10% owner could be interpreted as a lack of confidence in the company's near-term prospects or a signal that the stock price may be nearing a peak.
• The sale of over $17 million worth of stock represents a substantial divestment by a key executive.

Related Party Transactions

• August J. Troendle, the Reporting Person, is the sole manager and controlling unit holder of Medpace Investors, LLC, which indirectly holds 4,733,019 shares of Medpace Holdings, Inc. common stock.

Stakeholder Impact

• Shareholders may interpret the insider selling as a bearish signal, potentially leading to negative sentiment and downward pressure on the stock price.

Key Dates

Recommendation

The significant insider selling by the CEO and 10% owner, August J. Troendle, warrants caution. While not necessarily indicative of fundamental issues, such sales can signal that the insider believes the stock is fully valued or that personal diversification is a priority. Investors should monitor future insider activity and company performance closely before making further investment decisions, maintaining a 'hold' position for now.

Keywords

Medpace Holdings, MEDP, Insider Sale, Form 4, CEO, Director, 10% Owner, Stock Transaction